Business · 27/07/2022Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Ivax's Chloramphenicol Capsules
Summary
The FDA is withdrawing approval of Ivax Pharmaceuticals' abbreviated new drug application for chloramphenicol capsules, 250mg, following Ivax's request and waiver of a hearing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →